메뉴 건너뛰기




Volumn 5, Issue 1, 2016, Pages 53-63

Neonatal Iron Supplementation Induces Striatal Atrophy in Female YAC128 Huntington's Disease Mice

Author keywords

dietary iron; Huntington's disease; mouse model; neurodegeneration

Indexed keywords

IRON; IRON INTAKE;

EID: 84991336331     PISSN: 18796397     EISSN: 18796400     Source Type: Journal    
DOI: 10.3233/JHD-150182     Document Type: Article
Times cited : (12)

References (41)
  • 1
    • 0027480960 scopus 로고
    • A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's disease collaborative research group
    • A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group. Cell. 1993;72(6):971-83.
    • (1993) Cell. , vol.72 , Issue.6 , pp. 971-983
  • 2
    • 34247120606 scopus 로고    scopus 로고
    • The relationship between CAG repeat length and age of onset differs for Huntington's disease patients with juvenile onset or adult onset
    • Andresen JM, Gayan J, Djousse L, Roberts S, Brocklebank D, Cherny SS, et al. The relationship between CAG repeat length and age of onset differs for Huntington's disease patients with juvenile onset or adult onset. Ann Hum Genet. 2007;71(Pt 3):295-301.
    • (2007) Ann Hum Genet. , vol.71 , pp. 295-301
    • Andresen, J.M.1    Gayan, J.2    Djousse, L.3    Roberts, S.4    Brocklebank, D.5    Cherny, S.S.6
  • 3
    • 12144288251 scopus 로고    scopus 로고
    • Venezuelan kindreds reveal that genetic and environmental factors modulate Huntington's disease age of onset
    • Wexler NS, Lorimer J, Porter J, Gomez F, Moskowitz C, Shackell E, et al. Venezuelan kindreds reveal that genetic and environmental factors modulate Huntington's disease age of onset. Proc Natl Acad SciUSA. 2004;101(10):3498-503.
    • (2004) Proc Natl Acad SciUSA. , vol.101 , Issue.10 , pp. 3498-3503
    • Wexler, N.S.1    Lorimer, J.2    Porter, J.3    Gomez, F.4    Moskowitz, C.5    Shackell, E.6
  • 4
    • 84885404060 scopus 로고    scopus 로고
    • Correction: Iron accumulates in Huntington's disease neurons: Protection by deferoxamine
    • Chen J, Marks E, Lai B, Zhang Z, Duce JA, Lam LQ, et al. Correction: Iron accumulates in Huntington's disease neurons: Protection by deferoxamine. PLoS One. 2013;8(11):e77023.
    • (2013) PLoS One. , vol.8 , Issue.11
    • Chen, J.1    Marks, E.2    Lai, B.3    Zhang, Z.4    Duce, J.A.5    Lam, L.Q.6
  • 6
    • 84863806222 scopus 로고    scopus 로고
    • Alterations in brain transition metals in Huntington disease: An evolving and intricate story
    • Rosas HD, Chen YI, Doros G, Salat DH, Chen NK, Kwong KK, et al. Alterations in brain transition metals in Huntington disease: An evolving and intricate story. Arch Neurol. 2012;69(7):887-93.
    • (2012) Arch Neurol. , vol.69 , Issue.7 , pp. 887-893
    • Rosas, H.D.1    Chen, Y.I.2    Doros, G.3    Salat, D.H.4    Chen, N.K.5    Kwong, K.K.6
  • 9
    • 5444229092 scopus 로고    scopus 로고
    • Cystamine increases L-cysteine levels in Huntington's disease transgenic mouse brain and in a PC12 model of polyglutamine aggregation
    • Fox JH, Barber DS, Singh B, Zucker B, Swindell MK, Norflus F, et al. Cystamine increases L-cysteine levels in Huntington's disease transgenic mouse brain and in a PC12 model of polyglutamine aggregation. J Neurochem. 2004;91(2):413-22.
    • (2004) J Neurochem. , vol.91 , Issue.2 , pp. 413-422
    • Fox, J.H.1    Barber, D.S.2    Singh, B.3    Zucker, B.4    Swindell, M.K.5    Norflus, F.6
  • 10
    • 0030919567 scopus 로고    scopus 로고
    • Oxidative damage and metabolic dysfunction in Huntington's disease: Selective vulnerability of the basal ganglia
    • Browne SE, Bowling AC, MacGarvey U, Baik MJ, Berger SC, Muqit MM, et al. Oxidative damage and metabolic dysfunction in Huntington's disease: Selective vulnerability of the basal ganglia. Ann Neurol. 1997;41(5):646-53.
    • (1997) Ann Neurol. , vol.41 , Issue.5 , pp. 646-653
    • Browne, S.E.1    Bowling, A.C.2    MacGarvey, U.3    Baik, M.J.4    Berger, S.C.5    Muqit, M.M.6
  • 11
    • 84955415198 scopus 로고    scopus 로고
    • Redoxand non-redox-metal-induced formation of free radicals and their role in human disease
    • ValkoM, Jomova K, Rhodes CJ,Kuca K, Musilek K. Redoxand non-redox-metal-induced formation of free radicals and their role in human disease. Arch Toxicol. 2016;90(1): 1-37.
    • (2016) Arch Toxicol. , vol.90 , Issue.1 , pp. 1-37
    • Valko, M.1    Jomova, K.2    Rhodes, C.J.3    Kuca, K.4    Musilek, K.5
  • 12
    • 23844482456 scopus 로고    scopus 로고
    • Clioquinol down-regulates mutant huntingtin expression in vitro and mitigates pathology in a Huntington's disease mouse model
    • NguyenT,HambyA, MassaSM.Clioquinol down-regulates mutant huntingtin expression in vitro and mitigates pathology in a Huntington's disease mouse model. Proc Natl Acad Sci U S A. 2005;102(33):11840-5.
    • (2005) Proc Natl Acad Sci U S A , vol.102 , Issue.33 , pp. 11840-11845
    • Nguyen, T.1    Hamby, A.2    Massa, S.M.3
  • 13
    • 34247116462 scopus 로고    scopus 로고
    • Increased murine neonatal iron intake results in Parkinson-like neurodegeneration with age
    • Kaur D, Peng J, Chinta SJ, Rajagopalan S, Di Monte DA, Cherny RA, et al. Increased murine neonatal iron intake results in Parkinson-like neurodegeneration with age. Neurobiol Aging. 2007;28(6):907-13.
    • (2007) Neurobiol Aging. , vol.28 , Issue.6 , pp. 907-913
    • Kaur, D.1    Peng, J.2    Chinta, S.J.3    Rajagopalan, S.4    Di Monte, D.A.5    Cherny, R.A.6
  • 14
    • 2542586995 scopus 로고    scopus 로고
    • Use of vitamin, mineral, nonvitamin, and nonmineral supplements in the United States: The 1987, 1992, and 2000 National Health Interview Survey results
    • Millen AE, Dodd KW, Subar AF. Use of vitamin, mineral, nonvitamin, and nonmineral supplements in the United States: The 1987, 1992, and 2000 National Health Interview Survey results. J Am Diet Assoc. 2004;104(6): 942-50.
    • (2004) J Am Diet Assoc. , vol.104 , Issue.6 , pp. 942-950
    • Millen, A.E.1    Dodd, K.W.2    Subar, A.F.3
  • 16
    • 84923008546 scopus 로고    scopus 로고
    • Neonatal iron supplementation potentiates oxidative stress, energetic dysfunction and neurodegeneration in the R6/2 mouse model of Huntington's disease
    • Berggren KL, Chen J, Fox J, Miller J, Dodds L, Dugas B, et al. Neonatal iron supplementation potentiates oxidative stress, energetic dysfunction and neurodegeneration in the R6/2 mouse model of Huntington's disease. Redox Biol. 2015;4:363-74.
    • (2015) Redox Biol. , vol.4 , pp. 363-374
    • Berggren, K.L.1    Chen, J.2    Fox, J.3    Miller, J.4    Dodds, L.5    Dugas, B.6
  • 17
    • 16044373842 scopus 로고    scopus 로고
    • Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice
    • Mangiarini L, Sathasivam K, Seller M, Cozens B, Harper A, Hetherington C, et al. Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell. 1996;87(3):493-506.
    • (1996) Cell. , vol.87 , Issue.3 , pp. 493-506
    • Mangiarini, L.1    Sathasivam, K.2    Seller, M.3    Cozens, B.4    Harper, A.5    Hetherington, C.6
  • 18
    • 0033136692 scopus 로고    scopus 로고
    • A YAC mouse model for Huntington's disease with full-length mutant huntingtin, cytoplasmic toxicity, and selective striatal neurodegeneration
    • Hodgson JG, Agopyan N, Gutekunst CA, Leavitt BR, LePiane F, Singaraja R, et al. A YAC mouse model for Huntington's disease with full-length mutant huntingtin, cytoplasmic toxicity, and selective striatal neurodegeneration. Neuron. 1999;23(1):181-92.
    • (1999) Neuron. , vol.23 , Issue.1 , pp. 181-192
    • Hodgson, J.G.1    Agopyan, N.2    Gutekunst, C.A.3    Leavitt, B.R.4    LePiane, F.5    Singaraja, R.6
  • 19
    • 17644368893 scopus 로고    scopus 로고
    • Cognitive dysfunction precedes neuropathology and motor abnormalities in the YAC128 mouse model of Huntington's disease
    • Van Raamsdonk JM, Pearson J, Slow EJ, Hossain SM, Leavitt BR, Hayden MR. Cognitive dysfunction precedes neuropathology and motor abnormalities in the YAC128 mouse model of Huntington's disease. J Neurosci. 2005;25(16):4169-80.
    • (2005) J Neurosci. , vol.25 , Issue.16 , pp. 4169-4180
    • Van Raamsdonk, J.M.1    Pearson, J.2    Slow, E.J.3    Hossain, S.M.4    Leavitt, B.R.5    Hayden, M.R.6
  • 20
    • 67349151319 scopus 로고    scopus 로고
    • Mouse models of Huntington's disease and methodological considerations for therapeutic trials
    • Ferrante RJ. Mouse models of Huntington's disease and methodological considerations for therapeutic trials. Biochim Biophys Acta. 2009;1792(6):506-20.
    • (2009) Biochim Biophys Acta. , vol.1792 , Issue.6 , pp. 506-520
    • Ferrante, R.J.1
  • 22
    • 84898657803 scopus 로고    scopus 로고
    • Characterization of striatal neuronal loss and atrophy in the R6/2 mouse model of Huntington's disease
    • Dodds L, Chen J, Berggren K, Fox J. Characterization of striatal neuronal loss and atrophy in the R6/2 mouse model of Huntington's disease. PLoS Curr. 2014;6.
    • (2014) PLoS Curr. , vol.6
    • Dodds, L.1    Chen, J.2    Berggren, K.3    Fox, J.4
  • 23
    • 33646145729 scopus 로고    scopus 로고
    • Gender and genetic background effects on brain metal levels in APP transgenic and normal mice: Implications for Alzheimer beta-amyloid pathology
    • Maynard CJ, Cappai R, Volitakis I, Cherny RA, Masters CL, Li QX, et al. Gender and genetic background effects on brain metal levels in APP transgenic and normal mice: Implications for Alzheimer beta-amyloid pathology. J Inorg Biochem. 2006;100(5-6):952-62.
    • (2006) J Inorg Biochem. , vol.100 , Issue.5-6 , pp. 952-962
    • Maynard, C.J.1    Cappai, R.2    Volitakis, I.3    Cherny, R.A.4    Masters, C.L.5    Li, Q.X.6
  • 24
    • 84906558946 scopus 로고    scopus 로고
    • Altered selenium status in Huntington's disease: Neuroprotection by selenite in the N171-82Q mouse model
    • Lu Z, Marks E, Chen J, Moline J, Barrows L, Raisbeck M, et al. Altered selenium status in Huntington's disease: Neuroprotection by selenite in the N171-82Q mouse model. Neurobiol Dis. 2014;71:34-42.
    • (2014) Neurobiol Dis. , vol.71 , pp. 34-42
    • Lu, Z.1    Marks, E.2    Chen, J.3    Moline, J.4    Barrows, L.5    Raisbeck, M.6
  • 25
    • 84885768132 scopus 로고    scopus 로고
    • Systemic iron homeostasis
    • Ganz T. Systemic iron homeostasis. Physiol Rev. 2013; 93(4):1721-41.
    • (2013) Physiol Rev. , vol.93 , Issue.4 , pp. 1721-1741
    • Ganz, T.1
  • 27
    • 0041691176 scopus 로고    scopus 로고
    • Time course of early motor and neuropathological anomalies in a knock-in mouse model of Huntington's disease with 140 CAG repeats
    • Menalled LB, Sison JD, Dragatsis I, Zeitlin S, ChesseletMF. Time course of early motor and neuropathological anomalies in a knock-in mouse model of Huntington's disease with 140 CAG repeats. J Comp Neurol. 2003;465(1):11-26.
    • (2003) J Comp Neurol. , vol.465 , Issue.1 , pp. 11-26
    • Menalled, L.B.1    Sison, J.D.2    Dragatsis, I.3    Zeitlin, S.4    Chesselet, M.F.5
  • 28
    • 84885404060 scopus 로고    scopus 로고
    • Iron accumulates in Huntington's disease neurons: Protection by deferoxamine
    • Chen J, Marks E, Lai B, Zhang Z, Duce JA, Lam LQ, et al. Iron accumulates in Huntington's disease neurons: Protection by deferoxamine. PLoS One. 2013;8(10):e77023.
    • (2013) PLoS One. , vol.8 , Issue.10
    • Chen, J.1    Marks, E.2    Lai, B.3    Zhang, Z.4    Duce, J.A.5    Lam, L.Q.6
  • 29
    • 41849133159 scopus 로고    scopus 로고
    • Cerebral cortex and the clinical expression of Huntington's disease: Complexity and heterogeneity
    • Rosas HD, Salat DH, Lee SY, Zaleta AK, Pappu V, Fischl B, et al. Cerebral cortex and the clinical expression of Huntington's disease: Complexity and heterogeneity. Brain. 2008;131(Pt 4):1057-68.
    • (2008) Brain. , vol.131 , pp. 1057-1068
    • Rosas, H.D.1    Salat, D.H.2    Lee, S.Y.3    Zaleta, A.K.4    Pappu, V.5    Fischl, B.6
  • 30
    • 77956647381 scopus 로고    scopus 로고
    • Iron-export ferroxidase activity of beta-amyloid precursor protein is inhibited by zinc in Alzheimer's disease
    • Duce JA, Tsatsanis A, Cater MA, James SA, Robb E,Wikhe K, et al. Iron-export ferroxidase activity of beta-amyloid precursor protein is inhibited by zinc in Alzheimer's disease. Cell. 2010;142(6):857-67.
    • (2010) Cell. , vol.142 , Issue.6 , pp. 857-867
    • Duce, J.A.1    Tsatsanis, A.2    Cater, M.A.3    James, S.A.4    Robb, E.5    Wikhe, K.6
  • 31
    • 84903720548 scopus 로고    scopus 로고
    • SAPP modulates iron efflux from brain microvascular endothelial cells by stabilizing the ferrous iron exporter ferroportin
    • McCarthy RC, Park YH, Kosman DJ. sAPP modulates iron efflux from brain microvascular endothelial cells by stabilizing the ferrous iron exporter ferroportin. EMBO Rep. 2014;15(7):809-15.
    • (2014) EMBO Rep. , vol.15 , Issue.7 , pp. 809-815
    • McCarthy, R.C.1    Park, Y.H.2    Kosman, D.J.3
  • 32
    • 84883819112 scopus 로고    scopus 로고
    • Huntington disease arises from a combinatory toxicity of polyglutamine and copper binding
    • Xiao G, Fan Q,Wang X, Zhou B. Huntington disease arises from a combinatory toxicity of polyglutamine and copper binding. Proc Natl Acad Sci U S A. 2013;110(37):14995-5000.
    • (2013) Proc Natl Acad Sci U S A. , vol.110 , Issue.37 , pp. 14995-15000
    • Xiao, G.1    Fan, Q.2    Wang, X.3    Zhou, B.4
  • 33
    • 84915827829 scopus 로고    scopus 로고
    • BDNF and Huntingtin protein modifications by manganese: Implications for striatal medium spiny neuron pathology in manganese neurotoxicity
    • Stansfield KH, Bichell TJ, Bowman AB, Guilarte TR. BDNF and Huntingtin protein modifications by manganese: Implications for striatal medium spiny neuron pathology in manganese neurotoxicity. J Neurochem. 2014;131(5): 655-66.
    • (2014) J Neurochem. , vol.131 , Issue.5 , pp. 655-666
    • Stansfield, K.H.1    Bichell, T.J.2    Bowman, A.B.3    Guilarte, T.R.4
  • 34
    • 84923105977 scopus 로고    scopus 로고
    • Untargeted metabolic profiling identifies interactions between Huntington's disease and neuronal manganese status
    • Kumar KK, Goodwin CR, Uhouse MA, Bornhorst J, Schwerdtle T, Aschner M, et al. Untargeted metabolic profiling identifies interactions between Huntington's disease and neuronal manganese status. Metallomics. 2015;7(2): 363-70.
    • (2015) Metallomics. , vol.7 , Issue.2 , pp. 363-370
    • Kumar, K.K.1    Goodwin, C.R.2    Uhouse, M.A.3    Bornhorst, J.4    Schwerdtle, T.5    Aschner, M.6
  • 35
    • 0030070042 scopus 로고    scopus 로고
    • Iron and copper interact during their uptake and deposition in the brain and other organs of developing rats exposed to dietary excess of the two metals
    • Crowe A, Morgan EH. Iron and copper interact during their uptake and deposition in the brain and other organs of developing rats exposed to dietary excess of the two metals. J Nutr. 1996;126(1):183-94.
    • (1996) J Nutr. , vol.126 , Issue.1 , pp. 183-194
    • Crowe, A.1    Morgan, E.H.2
  • 36
    • 0030455852 scopus 로고    scopus 로고
    • Effects of iron deficiency and iron overload on manganese uptake and deposition in the brain and other organs of the rat
    • Chua AC, Morgan EH. Effects of iron deficiency and iron overload on manganese uptake and deposition in the brain and other organs of the rat. Biol Trace Elem Res. 1996;55(1-2):39-54.
    • (1996) Biol Trace Elem Res. , vol.55 , Issue.1-2 , pp. 39-54
    • Chua, A.C.1    Morgan, E.H.2
  • 37
    • 84901060509 scopus 로고    scopus 로고
    • Role of early life exposure and environment on neurodegeneration: Implications on brain disorders
    • Modgil S, Lahiri DK, Sharma VL, Anand A. Role of early life exposure and environment on neurodegeneration: Implications on brain disorders. Transl Neurodegener. 2014;3:9.
    • (2014) Transl Neurodegener. , vol.3 , pp. 9
    • Modgil, S.1    Lahiri, D.K.2    Sharma, V.L.3    Anand, A.4
  • 38
    • 84879137604 scopus 로고    scopus 로고
    • Genomic landscape of transcriptional and epigenetic dysregulation in early onset polyglutamine disease
    • Valor LM, Guiretti D, Lopez-Atalaya JP, Barco A. Genomic landscape of transcriptional and epigenetic dysregulation in early onset polyglutamine disease. J Neurosci. 2013;33(25):10471-82.
    • (2013) J Neurosci. , vol.33 , Issue.25 , pp. 10471-10482
    • Valor, L.M.1    Guiretti, D.2    Lopez-Atalaya, J.P.3    Barco, A.4
  • 39
    • 34948867658 scopus 로고    scopus 로고
    • Extrapolating brain development from experimental species to humans
    • Clancy B, Finlay BL, Darlington RB, Anand KJ. Extrapolating brain development from experimental species to humans. Neurotoxicology. 2007;28(5):931-7.
    • (2007) Neurotoxicology. , vol.28 , Issue.5 , pp. 931-937
    • Clancy, B.1    Finlay, B.L.2    Darlington, R.B.3    Anand, K.J.4
  • 41
    • 40449086665 scopus 로고    scopus 로고
    • Dose translation from animal to human studies revisited
    • Reagan-Shaw S, Nihal M, Ahmad N. Dose translation from animal to human studies revisited. FASEB J. 2008;22(3):659-61.
    • (2008) FASEB J. , vol.22 , Issue.3 , pp. 659-661
    • Reagan-Shaw, S.1    Nihal, M.2    Ahmad, N.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.